MBD2 selectively binds to methylated CpG sites within the Erdr1 promoter without altering its overall methylation level, repressing Erdr1 expression and promoting fibroblast differentiation into myofibroblasts, thus exacerbating IPF progression [81]. The gene discussed is MBD2; the disease is idiopathic pulmonary fibrosis.